![Xention](https://parsers.vc/logo/262b627e-827d-4bd4-ad47-e5f1045cfa9f-0.jpg)
Xention, a cardiovascular biotech company, specialised in the discovery and development of ion channel-modulating drugs.
Its assets have now been partnered with or acquired by pharmaceutical partners.
Copyright © 2024 Seroba. All rights reserved.
Legal | Privacy | Sustainability
Total raised: $12.6M
Investors 3
Date | Name | Website |
- | Seroba Lif... | seroba-lif... |
- | Forbion | forbion.co... |
- | Albion Cap... | albion.cap... |
Funding Rounds 1
Date | Series | Amount | Investors |
25.11.2010 | Series D | $12.6M | - |
Mentions in press and media 1
Date | Title | Description | Source |
25.11.2010 | Xention Closes £8M Series D Financing | Xention, Ltd., a Cambridge, UK-based biopharmaceutical company specializing in the discovery and dev... | finsmes.co... |